MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals submits analyst meet intimation

13 May 2025 Evaluate
Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has enclosed the presentation to be made in Investors / Analysts Call and the same is also being uploaded on the website of the Company.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1847.05
Dr. Reddys Labs. 1145.25
Cipla 1359.25
Lupin 2050.95
Zydus Lifesciences 1108.25
View more..